Back
Range Cancer Therapeutics ETF Vs. Hims & Hers Health Industry Stock Comparison
Sell
50
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.00
Seasonality Move:
2.55%
Buy
78
HIMS
Hims & Hers Health
Last Price:
30.67
Seasonality Move:
21.12%
Sell
50
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $13.82. The Score for CNCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Hims & Hers Health (HIMS)
is a Buy
Is Hims & Hers Health a Buy, Sell or Hold?
- The current Hims & Hers Health [HIMS] share price is $30.68. The Score for HIMS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- HIMS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $13.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight selling pressure.
HIMS Stock Price Chart
What is Hims & Hers Health's stock price today?
-
The Hims & Hers Health share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing slight buying pressure.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 41.18 | Sell |
| Chaikin Money Flow: | -729 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.74 - 15.38) | Sell |
| Bollinger Bands (100): | (14.11 - 15.45) | Sell |
HIMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.85 | Buy |
| Relative Strength Index (14 RSI): | 64.78 | Buy |
| Chaikin Money Flow: | 2627858 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.89 - 26.53) | Buy |
| Bollinger Bands (100): | (15.78 - 23.08) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.5 | Buy |
| 20-day SMA: | 14.47 | Sell |
| 50-day SMA: | 14.78 | Sell |
| 200-day SMA: | 15.03 | Sell |
| 8-day EMA: | 13.78 | Buy |
| 20-day EMA: | 14.22 | Sell |
| 50-day EMA: | 14.59 | Sell |
| 200-day EMA: | 14.54 | Sell |
HIMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.64 | Buy |
| 20-day SMA: | 23.51 | Buy |
| 50-day SMA: | 21.03 | Buy |
| 200-day SMA: | 17.57 | Buy |
| 8-day EMA: | 26.42 | Buy |
| 20-day EMA: | 24.23 | Buy |
| 50-day EMA: | 21.83 | Buy |
| 200-day EMA: | 17.57 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hims & Hers Health Earnings Growth & HIMS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.13 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hims & Hers Health Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||